Quarterly Result11 Aug 2025, 10:12 am
Remedium Lifecare Reports Q1 PAT of ₹464.88 Lakh, More Than Doubling FY25 Profit
AI Summary
Remedium Lifecare Ltd., a leading player in the pharmaceutical supply chain and specialty chemicals sector, has announced its financial results for the quarter ended June 30, 2025. The company reported a Profit After Tax (PAT) of ₹464.88 lakhs, a significant improvement from the loss of ₹204.60 lakhs recorded in the previous quarter. This performance underscores the company’s strategic execution and resilience, positioning it well for continued growth in the coming quarters.
Key Highlights
- Q1 PAT of ₹464.88 lakhs, more than doubling the annual profit of FY25
- Revenue from operations of ₹11,336.67 lakhs
- Profit Before Tax (PBT) of ₹571.23 lakhs
- Strategic focus on operational efficiency and prudent financial management
- Plans to expand research and development (R&D) focus across key therapeutic areas
- Prioritizing global expansion and strengthening presence in existing markets